US-based contract research organisation (CRO) Accelovance, which focuses on oncology, vaccines, and general medicine, says Mark Gelder has joined the company as Vice President Medical Affairs, Oncology.
Dr Gelder brings more than 25 years of oncology clinical trial and drug development experience to the Rockville, MD-based firm. He has extensive regulatory experience with the FDA and EMA and has worked closely with community and academic oncologists and oncology cooperative groups.
Dr Gelder has also held leadership roles in development and medical affairs groups at both small and large pharmaceutical companies, including Inovio Pharmaceuticals, Heron Therapeutics, GE Healthcare, Bayer, Wyeth, and Pfizer.
He will be based at Accelovance's Philadelphia, PA office.
